EU External Trade - Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing vitamins or other products of heading|2936

Extra-EU sourcing of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing vitamins or other products of heading|2936 is highly concentrated. 🇺🇸 United States captures 46.1% of imports (€318.4M), followed by 🇳🇴 Norway (16.4%). With an HHI of 2699, this Concentrated market exposes the EU to supply dependency risks.

The EU exports Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing vitamins or other products of heading|2936 to 5 extra-EU markets, reflecting solid diversification. 🇷🇺 Russia remains the largest client (19.2%, €874.2M), followed by 🇷🇺 Russia, 🇬🇧 United Kingdom, 🇨🇭 Switzerland.

Within the EU, 🇧🇪 Belgium concentrates 42.1% of Medicaments (excluding goods of heading|3002, 3005|or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, containing vitamins or other products of heading|2936 imports, well ahead of 🇩🇪 Germany (23.7%). The top importing member states are 🇧🇪 Belgium, 🇩🇪 Germany, 🇦🇹 Austria.

In 2025, imports were rising (6.9%) and exports rising (14.4%) compared to the previous year.